HUMANA INC
NYSE: HUM·Louisville, Kentucky·CIK 0000049071
- Price
- $461.25
- Base IV
- $393.98
Valuation snapshot
At $461.25, the price sits between our base case ($393.98) and bull case ($677.62).
Values per share, from an .
- No growth
- …
- Loading earnings power
- Base case
- $393.98
- 85% of the price · range $159.38–$677.62
- Price vs base case
- 17% above
- $461.25 against $393.98
- Base case · our researched forecast, 2026-11-12See the research ↗
- Price vs base · derived: price − base caseWhat the price expects ↗
- Price · StockValuer price feed, 2026-11-16 closeno link today
The price has risen 3.3% since this valuation was struck on 2026-11-12, so some of the gap opened up after these figures were set.
Whisker on the base case runs bear $159.38 to bull $677.62. Values per share.
Price against each value
- Bear case
- $159.38
- Price 189% above
- No growth
- …
- —
- Base case
- $393.98
- Price 17% above
What does Humana do?
Humana provides health insurance plans and integrated care services, including pharmacy benefits and primary care, to Medicare and Medicaid beneficiaries and other individuals seeking managed healthcare.
It brought in $7.1B of sales in the 12 months to Sep 2026.
Led by Jim Rechtin, President and Chief Executive Officer since 2024. Humana Reports First Quarter 2026 Financial Results; Affirms Full Year 2026 Adjusted Financial Guidance
- Industry
- Financials
- Based in
- Louisville, Kentucky
- Trades on
- NYSE as HUM
Here is where each dollar a customer pays ends up. Out of every $1 of sales in the 12 months to Sep 2026, about 18¢ was left as profit after every cost, interest and tax. The biggest cost is running the business, 66¢ of every dollar.
- Running the business66¢
- Interest and other costs9¢
- Tax6¢
- Other items after tax1¢
- Left as profit18¢
Who pays Humana, and for what?
Humana sells health insurance, mainly Medicare plans, and provides pharmacy, primary care, and home health services through CenterWell. It receives premiums from members and government programs, and fees for services it provides.
Its customers include Medicare and Medicaid members, military personnel and their families, employers, government agencies, and people who use its pharmacy, clinic, and home health services.
Individual Medicare Advantage
70%Health plans for individuals eligible for Medicare; Humana receives payments from the federal government and may also charge members premiums and other cost sharing.
State-based contracts and other
11%Mainly health coverage for people enrolled in Medicaid and related state programs.
Group Medicare Advantage
7%Medicare plans offered through employers, often for retirees.
Medicare stand-alone prescription drug plans
5%Prescription drug coverage sold to people enrolled in Medicare.
CenterWell services
4%External services revenue from pharmacy, primary care, and home health services. The filing reports these lines together as CenterWell revenue.
Military services and other
1%Administrative services under government military health contracts, including TRICARE.
Where its work physically happens, beyond headquarters:
- Humana Green Bay administrative hub — Green Bay, United States. Humana identifies Green Bay as a key administrative location within its operating network supporting health-plan functions such as customer service, enrollment, and claims processing.
- Humana Arlington administrative hub — Arlington, United States. Humana identifies Arlington as a key administrative location within its operating network supporting health-plan functions such as customer service, enrollment, and claims processing.
How is the business doing?
Sales grew from $1.8B in 2020 to $5.8B in 2025, about 26% a year.
Running the business leaves about 34¢ of each sales dollar as operating profit, down from $2.75 in 2020.
After paying for its upkeep and new investment, it had $3.1B of cash to spare in the 12 months to Sep 2026.
What does management say it's aiming for?
Humana says it aims to help the people it serves achieve their best health by providing care and service when they need it.
““make it easier for the millions of people we serve to achieve their best health””
Who is responsible for the plan?
Jim RechtinPresident and Chief Executive OfficerLeads Humana as President and Chief Executive Officer and oversees the whole company, including its Insurance and CenterWell businesses. As CEO, he is accountable for the company's health insurance plans, mainly Medicare Advantage, and its CenterWell healthcare services, which together produce Humana's revenue.
- Aaron MartinPresident of Insurance (Insurance Segment President)
Leads Humana's Insurance segment, including the Medicare Advantage and Medicaid businesses. The Insurance segment sells health plans, mainly Medicare Advantage, and earns premium revenue from them.
- Japan MehtaChief Information Officer
Oversees Humana's digital and technology organization and its data systems. These technology and data systems support how Humana's health plans and care services run and how they serve members.
Roles checked November 12, 2026.
What management says it is working on now:
Grow Medicare Advantage membership
Management says its 2026 plan is to grow individual Medicare Advantage membership by about 25% from 2025, while pursuing pricing discipline.
Humana Inc. Second Quarter 2026 Prepared Management RemarksImprove care and customer experience
Management is emphasizing clinical care, member engagement, and service improvements as it works to improve health outcomes and retain members.
Humana Inc. Second Quarter 2026 Prepared Management RemarksImprove Medicare plan quality ratings
Humana says it is working to return to top-quartile Medicare plan quality results by Bonus Year 2028.
Humana Inc. Second Quarter 2026 Prepared Management RemarksExpand CenterWell and Medicaid
Management is continuing to expand its primary care, pharmacy, and home health services, along with its Medicaid business.
Humana Inc. Second Quarter 2026 Prepared Management RemarksSimplify operations and improve efficiency
Humana is pursuing a multi-year effort to reshape its costs, operating model, and technology systems as market conditions change.
Humana Inc. 2025 Form 10-K
- Adjusted earnings per share, 2026
- At least $9.00
- Humana Inc. Second Quarter 2026 Prepared Management Remarks
- Individual Medicare Advantage membership growth, 2026, compared with 2025
- Approximately 25%
- Humana Inc. Second Quarter 2026 Prepared Management Remarks
- Group Medicare Advantage membership growth, 2026
- Approximately 150,000 members
- Humana Inc. Second Quarter 2026 Prepared Management Remarks
- Medicare stand-alone prescription drug plan membership growth, 2026
- Approximately 1,000,000 members
- Humana Inc. Second Quarter 2026 Prepared Management Remarks
- Medicaid membership growth, 2026
- 25,000 to 100,000 members
- Humana Inc. Second Quarter 2026 Prepared Management Remarks
What's changing right now?
Growth is holding steady. In Q3 2026 it sold 33% more than a year earlier. The year before, quarters averaged 32%.
Its operating margin is narrower than a year ago: 4¢ per sales dollar, against 25¢.
Since Oct 2026 the share price has risen 11%, from $416.68 to $461.25.
Recently
November 6, 2026
Consolidated benefit (medical loss) ratio, third quarter changed to 93.9%
Healthcare Finance News: Humana raises outlookNovember 6, 2026
Average Medicare Advantage Star rating (payment-year basis) changed to 4.17 stars
Fierce Healthcare: Humana Q3 2026July 29, 2026
Insurance benefit ratio, second quarter changed to 91.2%
Humana 2Q26 results
Coming up
2026-12-10
Virtual investor update
Humana plans to review progress against its 2025 Investor Day framework and discuss initiatives intended to support earnings growth through 2028.
Humana Inc. Second Quarter 2026 Prepared Management Remarks2027-01
Illinois Medicaid contract expected to begin
Humana expects its newly awarded statewide Illinois Medicaid managed care contract to start operations.
Humana Inc. Second Quarter 2026 Prepared Management Remarks
Our own estimate moved too: the base case went from -$53.50 to $393.98 a share between our last two valuations. The biggest reason: Consolidated benefit (medical loss) ratio, third quarter moved from an unreported prior value to 93.9%, as reported in Healthcare Finance News: Humana raises outlook.
What could go wrong?
No business is a sure thing. These are the risks we found, starting with the ones the company itself names. Where a risk would change part of the valuation, it says which.
Medical costs may exceed estimates
Humana sets many premiums before it knows the full cost of members' care. If claims, drug costs, or use of services exceed its estimates, it may not be able to recover those costs during the contract year.
From the company's own filingsWould hit how much of each sale it keepsHumana Inc. 2025 Form 10-K
Dependence on government programs
A large portion of Humana's revenue comes from Medicare, Medicaid, and military programs. Changes in government payments, rules, or eligibility could affect its revenue and costs.
From the company's own filingsWould hit how fast sales growHumana Inc. 2025 Form 10-K
Competition and member retention
Humana competes with insurers that may have greater resources in some markets. Members can change plans during enrollment periods, and pressure to keep prices competitive may limit premium increases.
From the company's own filingsWould hit how fast sales growHumana Inc. 2025 Form 10-K
Medicare plan quality ratings
Lower Medicare plan quality ratings can reduce government bonus payments and make plans less attractive to members. Humana says ratings and related payments are affected by changing rules and measures.
From the company's own filingsWould hit how fast sales growHumana Inc. 2025 Form 10-K
Strategy and transformation execution
Humana's plans depend on executing its Medicare and state contract strategies, growing CenterWell, and integrating care. Failure to carry out these efforts could harm its business and results.
From the company's own filingsWould hit how fast sales growHumana Inc. 2025 Form 10-K
Cybersecurity and systems disruption
Humana and its service providers handle sensitive health and business data. A cyberattack or systems failure could interrupt operations, expose information, lead to penalties or lawsuits, and damage trust.
From the company's own filingsWould hit how much of each sale it keepsHumana Inc. 2025 Form 10-K
Market exits are expected to affect about 600,000 members in 2027.
From our researchWould hit how fast sales growFierce Healthcare: Humana 2027 MA bid planning
The Q3 2026 medical loss ratio of 93.9% was up from 91.1% a year earlier.
From our researchWould hit how much of each sale it keepsHealthcare Finance News: Humana raises outlook
Is it a good business?
From 2016 to 2025 it earned between 8% and 31% on the capital invested in it, a median of 14%. Its cost of capital in the latest valuation is 7.0%; returns were above it in every one of the 10 years.
From 2016 to 2025 it earned between 6% and 25% on its shareholders' equity, a median of 17%.
Over 10 years its operating margin ranged from 3¢ to $2.75 per sales dollar, a median of 90¢.
Cost of capital 7.0%
The number of shares has held roughly steady over the past year.
It owes $5.6B more than it holds in cash, about 2.3 years of operating profit.
What might it be worth?
The Valuation snapshot at the top of this page shows the answer. This is how we got there. A share is a slice of the business, so what a share is worth depends on what the business can earn for its owners from here on. We estimate that three ways, from cautious to hopeful, and call the result .
Today a share costs $461.25. Our put its value between $159.38 and $677.62, with $393.98 in the middle. Underneath sit two simpler checks: what it would cost to rebuild the business, its , and what today's profit is worth with no growth at all, its .
Bear case, $159.38
This scenario assumes Humana's recent fast growth slows sharply and its profits stay squeezed by high medical costs, as they were in the latest quarter when profit nearly vanished.
Base case, $393.98
This scenario assumes Humana's fast recent growth gradually cools while its profits recover from a weak 2026 toward the levels it earned in 2025.
Bull case, $677.62
This scenario assumes Humana keeps growing quickly for another year or two and that better quality ratings bring its profits back to, or slightly above, its stronger 2025 levels.
Another way in: instead of asking what the business is worth, ask what today's price assumes it will do.
Why the gap?
The price expects more than we do.Price above value: 17%
For Humana to be worth today's $461.25, sales would need to grow about 13.7% a year. We assume 10.2%. Over the last 5 years, sales grew 25.4% a year.
Or, if sales grow 10.2% as we assume, the price works with a profit margin of 46.1% (we assume 40.0%).
Keep in mind: this is one way to read the price. Investors might be expecting other things, like higher profits or lower risk.
Do you think sales can grow 13.7% a year?
Try your own numbersWe're not very sure of this range: it scores 35 out of 100 on our checks. The weakest point is margin predictability.
Test the assumptions
Our base value of $393.98 rests on three assumptions. Change any of them to see how the value per share responds.
- Revenue growth, 5-year average10.2%
- Operating margin40.0%
- Long-term growth rate3.0%
This is an educational explanation built from public filings and our own research, not investment advice. It does not tell you whether to buy or sell anything.
Base estimate
$393.98 -14.6%


